Cornelius A Thiels1,2, Johnathon M Aho1,3, Aoidhnait S Fahy1, Maile E Parker1, Amy E Glasgow2, Kathleen S Berns4, Elizabeth B Habermann2, Scott P Zietlow1, Martin D Zielinski5. 1. Department of Surgery, Mayo Clinic Rochester, 200 First Street SW, Rochester, MN, 55905, USA. 2. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA. 3. Biomedical Engineering and Physiology, Rochester, MN, USA. 4. Medical Transport, Mayo Clinic, Rochester, MN, USA. 5. Department of Surgery, Mayo Clinic Rochester, 200 First Street SW, Rochester, MN, 55905, USA. Zielinski.Martin@mayo.edu.
Abstract
INTRODUCTION: Despite advances in trauma care, hemorrhage continues to be the leading cause of preventable mortality in trauma. The evidence to support its use in non-trauma patients is limited. We aim to report our experience with prehospital blood product transfusion. We hypothesize that it is safe, appropriately utilized, and that our protocol, which was designed for trauma patients, is adaptable to fit the needs of non-trauma patients. METHODS: Patients transfused with blood products, packed red blood cells (pRBCs) or plasma, in the prehospital environment between 2002 and 2014 were included. Trauma patients were compared to non-trauma patients using descriptive statistics. RESULTS: A total of 857 patients (n = 549 trauma and n = 308 non-trauma) were transfused with pRBCs (76 %, n = 654, mean 1.6 ± 1.1 units en route), plasma (53 %, n = 455, mean 1.7 ± 0.7 unit), or both (29 %, n = 252) during ground (12 %) or air (84 %) critical care transport. Mean age was 60.8 ± 21.6 years with 60.1 % (n = 515) males. Subsequently, in-hospital blood transfusions were performed in 80 % of patients, operations in 44 %, and endoscopy in 31 %. Five percent (n = 41) of patients did not require any of these interventions. Thirty-day mortality rate was 18 %, and one patient (<0.01 %) had a transfusion reaction. The majority of patients were non-trauma (n = 549, 64 %). Of the non-trauma patients, 219 (40 %) were surgical, 193 (35 %) gastrointestinal bleeds, and 137 (25 %) medical. CONCLUSION: Both non-trauma and trauma patients require blood products for life threatening hemorrhage and the majority required further interventions. Further research on the benefits of transfusion among non-trauma patients is warranted.
INTRODUCTION: Despite advances in trauma care, hemorrhage continues to be the leading cause of preventable mortality in trauma. The evidence to support its use in non-traumapatients is limited. We aim to report our experience with prehospital blood product transfusion. We hypothesize that it is safe, appropriately utilized, and that our protocol, which was designed for traumapatients, is adaptable to fit the needs of non-traumapatients. METHODS:Patients transfused with blood products, packed red blood cells (pRBCs) or plasma, in the prehospital environment between 2002 and 2014 were included. Traumapatients were compared to non-traumapatients using descriptive statistics. RESULTS: A total of 857 patients (n = 549 trauma and n = 308 non-trauma) were transfused with pRBCs (76 %, n = 654, mean 1.6 ± 1.1 units en route), plasma (53 %, n = 455, mean 1.7 ± 0.7 unit), or both (29 %, n = 252) during ground (12 %) or air (84 %) critical care transport. Mean age was 60.8 ± 21.6 years with 60.1 % (n = 515) males. Subsequently, in-hospital blood transfusions were performed in 80 % of patients, operations in 44 %, and endoscopy in 31 %. Five percent (n = 41) of patients did not require any of these interventions. Thirty-day mortality rate was 18 %, and one patient (<0.01 %) had a transfusion reaction. The majority of patients were non-trauma (n = 549, 64 %). Of the non-traumapatients, 219 (40 %) were surgical, 193 (35 %) gastrointestinal bleeds, and 137 (25 %) medical. CONCLUSION: Both non-trauma and traumapatients require blood products for life threatening hemorrhage and the majority required further interventions. Further research on the benefits of transfusion among non-traumapatients is warranted.
Authors: Deborah J Novak; Yu Bai; Rhonda K Cooke; Marisa B Marques; Magali J Fontaine; Jerome L Gottschall; Patricia M Carey; Richard M Scanlan; Eberhard W Fiebig; Ira A Shulman; Janice M Nelson; Sherri Flax; Veda Duncan; Jennifer A Daniel-Johnson; Jeannie L Callum; John B Holcomb; Erin E Fox; Sarah Baraniuk; Barbara C Tilley; Martin A Schreiber; Kenji Inaba; Sandro Rizoli; Jeanette M Podbielski; Bryan A Cotton; John R Hess Journal: Transfusion Date: 2015-03-30 Impact factor: 3.157
Authors: George L Higgins; Michael R Baumann; Kevin M Kendall; Michael A Watts; Tania D Strout Journal: Prehosp Disaster Med Date: 2012-06-12 Impact factor: 2.040
Authors: Pedro G R Teixeira; Kenji Inaba; Pantelis Hadjizacharia; Carlos Brown; Ali Salim; Peter Rhee; Timothy Browder; Thomas T Noguchi; Demetrios Demetriades Journal: J Trauma Date: 2007-12
Authors: Daniel Bodnar; Stephen Rashford; Sue Williams; Emma Enraght-Moony; Lachlan Parker; Benjamin Clarke Journal: Emerg Med J Date: 2012-12-22 Impact factor: 2.740
Authors: Daniel Bodnar; Stephen Rashford; Catherine Hurn; Jamie Quinn; Lachlan Parker; Katherine Isoardi; Sue Williams Journal: Emerg Med J Date: 2013-05-05 Impact factor: 2.740
Authors: Heather F Pidcoke; James K Aden; Alejandra G Mora; Matthew A Borgman; Philip C Spinella; Michael A Dubick; Lorne H Blackbourne; Andrew P Cap Journal: J Trauma Acute Care Surg Date: 2012-12 Impact factor: 3.313
Authors: Martin D Zielinski; Dustin L Smoot; James R Stubbs; Donald H Jenkins; Myung S Park; Scott P Zietlow Journal: Transfusion Date: 2013-01 Impact factor: 3.337
Authors: Matthew C Hernandez; Cornelius A Thiels; Johnathon M Aho; Elizabeth B Habermann; Martin D Zielinski; James A Stubbs; Donald H Jenkins; Scott P Zietlow Journal: J Trauma Acute Care Surg Date: 2017-09 Impact factor: 3.313
Authors: Aodhnait S Fahy; Cornelius A Thiels; Stephanie F Polites; Maile Parker; Michael B Ishitani; Christopher R Moir; Kathleen Berns; James R Stubbs; Donald H Jenkins; Scott P Zietlow; Martin D Zielinski Journal: Pediatr Surg Int Date: 2017-05-25 Impact factor: 1.827
Authors: Elisabeth C van Turenhout; Sebastiaan M Bossers; Stephan A Loer; Georgios F Giannakopoulos; Lothar A Schwarte; Patrick Schober Journal: Transfus Med Date: 2020-01-05 Impact factor: 2.019